Mechanisms of interleukin-4 effects on calcium signaling in airway smooth muscle cells

UMMS Affiliation

Department of Medicine, Division of Pulmonary, Allergy and Critical Care



Document Type



1-Phosphatidylinositol 3-Kinase; Animals; Blotting, Western; Calcium Signaling; Calcium-Transporting ATPases; Carbachol; Cattle; Cell Separation; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Interleukin-4; Muscarinic Agonists; Muscle, Smooth; Respiratory System; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases


Life Sciences | Medicine and Health Sciences


In airway smooth muscle cells, interleukin (IL)-4 inhibited both carbachol- and caffeine-induced calcium mobilization from the sarcoplasmic reticulum (SR). Because of the known signaling pathways for IL-4 and importance of calcium uptake in maintaining SR calcium stores shared by agonists and caffeine, it was hypothesized that this rapid inhibitory effect might depend on phosphatidylinositol 3-kinase (PI3K) and on inhibition of calcium uptake by the SR. Enzyme-dispersed bovine trachealis cells were loaded with Fura-2/acetoxymethyl ester, and changes in cytosolic calcium were imaged in single cells. Cells were pretreated with inhibitors of PI3K, either wortmannin (100 nM), LY294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] (50 microM), or deguelin (100 nM). Calcium transients in response to carbachol (10 microM) were significantly decreased to 0.34 +/- 0.10 of control after 20-min treatment with IL-4 but were 1.10 +/- 0.26 and 1.08 +/- 0.23 when wortmannin or deguelin, respectively, was added along with IL-4. LY294002 alone had nonspecific effects on transients. In other experiments, cyclopiazonic acid (CPA) (5 microM), an inhibitor of SR calcium uptake, decreased carbachol-stimulated transients within 4 min to 0.83 +/- 0.08 of control (n = 6). However, for cells treated with IL-4 (50 ng/ml) plus CPA, transients decreased significantly more, to only 0.51 +/- 0.05 (n = 6; p < 0.05). Longer exposures to IL-4 and a higher concentration of CPA (30 microM) gave similar results. It was concluded that IL-4 did not inhibit transients in the presence of PI3K antagonists but that it did in the presence of CPA. This suggested that IL-4 inhibited calcium transients by mechanisms dependent upon a wortmannin-sensitive PI3K but not by inhibition of calcium uptake into the SR.

Rights and Permissions

Citation: J Pharmacol Exp Ther. 2005 Apr;313(1):127-33. Epub 2005 Jan 5. Link to article on publisher's site

DOI of Published Version


Related Resources

Link to Article in PubMed

Journal Title

The Journal of pharmacology and experimental therapeutics

PubMed ID